Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled 2-year trial of tiotropium in COPD
2006-004610-41Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium 18 mcg once daily with Placebo (2 arms). Primary endpoint: Constant-load treadmill exercise duration at 96 weeks. Started Mar 2007; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-004610-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004610-41.